unknown
Stage
About
GRIP Molecular develops a molecular diagnostic platform using a CRISPR protease engine to rapidly detect pathogens such as bacteria, viruses, and fungi with molecular-grade accuracy in point-of-care and point-of-need settings.
Explore GRIP Molecular's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.